全文获取类型
收费全文 | 4697篇 |
免费 | 341篇 |
国内免费 | 14篇 |
专业分类
耳鼻咽喉 | 34篇 |
儿科学 | 141篇 |
妇产科学 | 78篇 |
基础医学 | 630篇 |
口腔科学 | 439篇 |
临床医学 | 446篇 |
内科学 | 1010篇 |
皮肤病学 | 157篇 |
神经病学 | 296篇 |
特种医学 | 374篇 |
外科学 | 449篇 |
综合类 | 27篇 |
预防医学 | 407篇 |
眼科学 | 41篇 |
药学 | 339篇 |
中国医学 | 40篇 |
肿瘤学 | 144篇 |
出版年
2023年 | 43篇 |
2022年 | 74篇 |
2021年 | 163篇 |
2020年 | 109篇 |
2019年 | 143篇 |
2018年 | 188篇 |
2017年 | 103篇 |
2016年 | 147篇 |
2015年 | 142篇 |
2014年 | 218篇 |
2013年 | 206篇 |
2012年 | 357篇 |
2011年 | 334篇 |
2010年 | 198篇 |
2009年 | 189篇 |
2008年 | 241篇 |
2007年 | 243篇 |
2006年 | 181篇 |
2005年 | 163篇 |
2004年 | 144篇 |
2003年 | 162篇 |
2002年 | 138篇 |
2001年 | 77篇 |
2000年 | 90篇 |
1999年 | 68篇 |
1998年 | 60篇 |
1997年 | 71篇 |
1996年 | 80篇 |
1995年 | 56篇 |
1994年 | 51篇 |
1993年 | 61篇 |
1992年 | 43篇 |
1991年 | 29篇 |
1990年 | 31篇 |
1989年 | 44篇 |
1988年 | 49篇 |
1987年 | 47篇 |
1986年 | 48篇 |
1985年 | 39篇 |
1984年 | 32篇 |
1983年 | 18篇 |
1982年 | 25篇 |
1981年 | 21篇 |
1980年 | 10篇 |
1978年 | 10篇 |
1977年 | 19篇 |
1976年 | 12篇 |
1975年 | 18篇 |
1971年 | 7篇 |
1969年 | 7篇 |
排序方式: 共有5052条查询结果,搜索用时 78 毫秒
1.
2.
ME BURGE AM JOSHUA CM McNEIL R HUI MJ BOYER R ABRAHAM 《Asia-Pacific Journal of Clinical Oncology》2005,1(1):47-52
Background: Pemetrexed and cisplatin have recently been shown to significantly improve survival compared with cisplatin alone. However, there are only limited data reflecting teaching hospital experience outside a clinical trial. Pemetrexed has only been available in Australia on a restricted basis since 2002. We reviewed our experience of patients treated on the Australian ‘Special Access Scheme’ at three major thoracic oncology units. Methods: Charts were reviewed for all patients enrolled on the scheme. Data was extracted on age, World Health Organization (WHO) performance status, histology, prior therapy, time from diagnosis to starting pemetrexed, chemotherapy (pemetrexed alone or with a platinum), cycle number, response rate, actuarial progression‐free and overall survival. Doses were cisplatin 75 mg/m2 or carboplatin AUC = 5 and pemetrexed 500 mg/m2 every 21 days. Results: 52 patients (32 male and 20 female) were reviewed. Median age was 58 years and 88% were WHO 0–1. Histology included 54% epithelial, 17% biphasic (epithelial and sarcomatoid) and 21% undefined. The median time from diagnosis to administration of pemetrexed was 145 days. Sixty‐five percent had minimal surgical intervention with video assisted thoracoscopy, pleurodesis and biopsy, while 19% had received prior palliative radiation. Seventy‐one percent were chemotherapy naïve, the remaining 29% having received previous platinum and/or gemcitabine regimens. Twenty‐three percent had pemetrexed alone, 35% in combination with carboplatin and 42% with cisplatin. The median number of cycles was 4 (range 1–13). The response rate was 33%. No toxicity was observed in 20% grade 3–4 toxicity in 10% (majority nausea/vomiting). The median progression‐free and overall survival times from starting pemetrexed were 184 days and 298 days, respectively. Conclusions: Pemetrexed‐based regimens are safe and effective in a community setting in malignant mesothelioma. 相似文献
3.
Carlos Alberto Herrero de Morais Norberti Bernardineli Roberto B Garcia Marco A H Duarte Danilo M Z Guerisoli 《Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics》2006,102(3):417-421
OBJECTIVE: The aim of this study was to evaluate the biocompatibility of Portland cement with the addition of iodoform, compared to MTA (ProRoot). STUDY DESIGN: Eighteen Wistar albino rats were divided into 3 groups of 6 animals each. Polyethylene tubes were filled either with freshly mixed MTA or Portland cement mixed with iodoform (20% wt/wt) and implanted subcutaneously. An empty tube served as control. After 7, 30, or 60 days, the implants together with the surrounding tissues were removed in blocks. Sections were evaluated for the presence and thickness of a fibrous capsule, presence of granulation tissue, and the severity of inflammatory response. Data were submitted to nonparametric statistical analysis with individual comparisons between groups at a significance level of P < 0.05. RESULTS: There were no differences between inflammatory responses at 7 and 30 days. After 60 days from surgical removal, there was significantly more tissue reaction to the MTA and Portland cement compared to the control group. CONCLUSION: There were no significant differences regarding inflammatory responses between MTA and Portland cement with iodoform after 7, 30, or 60 days. After 60 days, the fibrous capsule around the Portland cement appeared more organized than tissue surrounding MTA implants. After 60 days, there was still a significantly increased tissue reaction to the 2 cements compared to the empty polyethylene tubes. 相似文献
4.
Immunological and echocardiographic evaluation of decellularized versus cryopreserved allografts during the Ross operation. 总被引:3,自引:0,他引:3
Francisco Diniz Affonso da Costa Pascal Maria Dohmen Daniele Duarte Cristina von Glenn Sérgio Veiga Lopes Hermínio Haggi Filho Marise Brenner Affonso da Costa Wolfgang Konertz 《European journal of cardio-thoracic surgery》2005,27(4):572-578
OBJECTIVE: Compare the immunological and echocardiographic data of decellularized versus cryopreserved allografts used for RVOT reconstruction during Ross operation. METHODS: From 16/01/03 thru 07/10/03, 20 Ross operations were performed using decellularized (n=11) or cryopreserved (n=9) allografts. Echocardiography was done at discharge, 1, 3, 6 and 12 months and annually thereafter. Samples for determination of antibodies against HLA class I and II were obtained preoperatively and at days 5, 10, 30, 90 and 180 postoperatively. These samples were tested by the ELISA method in LAT-M dishes (unspecific) for identification of circulating antibodies and the results expressed as mean sample values (Is=DO/cutoff). If positive, LAT-E (specific) was performed and PRA levels determined. RESULTS: There was no mortality. Cryopreserved allografts showed marked Is values elevations for class I and II antibodies which started at the first month and remained elevated up to 6 months. In contrast, of the patients receiving decellularized allografts, seven remained negative, two patients had only marginal elevation of class I antibodies and two patients showed abnormal elevations of PRA levels. This response happened earlier than in the cryopreserved group, starting on the 5th postoperative day and has returned to baseline levels in one case. Echocardiography showed mild, but significant, elevation of gradients in cryopreserved valves but none in the decellularized. CONCLUSIONS: Decellularized allografts had normal function up to 18 months and showed important reduction of the immunogenic response when compared to cryopreserved valves. 相似文献
5.
6.
P E Marchiori A J Duarte M I Birolli C A Figueiredo M Scaff J L De Assis 《Arquivos de neuro-psiquiatria》1988,46(3):248-253
A significant decline of CD3 cell detected by rosettes and a significant increased of B cell populations were observed. The total CD3+, helper CD4+ and suppressor CD8+ T-cell subsets showed no significant variation em relation to sex, age thymectomy and corticotherapy by monoclonal antibodies. 相似文献
7.
8.
9.
Elsa J. Brochmann Murray Samuel S. Murray Mario Grisanti Maria Eugenia L. Duarte Marshall R. Urist 《Journal of orthopaedic research》1997,15(4):585-592
The SENCAR (sensitive to carcinogenesis) mouse is a unique tool for investigating the interaction between a specific defect in intracellular signaling, dietary calcium, and metabolic bone disease. The SENCAR mouse was developed by selective breeding for enhanced sensitivity to two-stage carcinogenesis. Its major genetic defect, which renders it exquisitely sensitive to stimulation with diacylglycerol or phorbol esters, is in the regulatory domain of protein kinase C, one of the primary intracellular mediators of hormonal effects. At sexual maturity, SENCAR mice are large and have big bones, but our previous pharmacokinetic studies showed that they accumulate lesscalcium under normal conditions and lose more calcium under adverse conditions than do other, standard strains of mice. To histologically define the effect of low dietary calcium on bone metabolism, we performed histomorphometric analysis of tetracycline-labeled sections of femoral bone from male SENCAR mice maintained on calcium-sufficient and calcium-deficient diets during the critical period from 10 to 14 weeks of age. The bone volume, absolute osteoid volume, and mineral apposition rate were lower at 14 than at 10 weeks of age in SENCAR mice fed 0.02 or 0.6% calcium diets. Calcium deficiency increased the architectural disarray and the probability of observing focal discontinuities in the growth plate. Thus, characteristic features of impaired bone metabolism (low bone volume and apposition rate) develop early in SENCAR mice and are exacerbated by low dietary calcium. Detailed examinations of the histology and biochemistry of SENCAR mouse bone will provide insights into the mechanisms by which specific defects in the signal transduction of protein kinase C contribute to impaired bone metabolism. 相似文献
10.